Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The American Journal of Gastroenterology|November 26, 2024
Small-Molecule Neutrophil Modulator ADS051 is Safe and Well-Tolerated in a Phase 1 Single Ascending Dose StudyAdam S Cheifetz, Jessica R Allegretti, Megan Quintas, et al.Transplantation|January 1, 1992
The strong correlation of cytotoxic T lymphocyte-specific serine protease gene transcripts with renal allograft rejectionM L Lipman, A C Stevens, R C Bleackley, et al.Gastroenterology|February 24, 2001
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitisA Bitton, M A Peppercorn, D A Antonioli, et al.Gastroenterology|November 1, 1992
DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitisC E Rubin, R C Haggitt, G C Burmer, et al.Gastroenterology|February 1, 1996
Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitisT A Brentnall, R C Haggitt, P S Rabinovitch, et al.The American Journal of Pathology|September 12, 2000
The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasiaS N Agoff, T A Brentnall, D A Crispin, et al.The American Journal of Gastroenterology|January 9, 2025
Safety, Pharmacokinetics, and Clinical Efficacy of ADS051, a Neutrophil Modulator, in Ulcerative Colitis: Results of a Randomized Phase 1b TrialJessica R Allegretti, Adam S Cheifetz, Parambir S Dulai, et al.Molecular Psychiatry|October 29, 2014
Evidence that small molecule enhancement of β-hexosaminidase activity corrects the behavioral phenotype in Dutch APP(E693Q) mice through reduction of ganglioside-bound AβE M Knight, H N Williams, A C Stevens, et al.Pageof 3